
Artificial Intelligence
Nutriselect And The Center For Applied Health Sciences Partner To Advance AI-Driven Personalized Supplement Science
By EIN Presswire

Strategic collaboration aims to validate NutriSelect's AI supplement engine through clinical trials and biomarker-based performance optimization.
The partnership will leverage NutriSelect’s patent pending recommendation engine — powered by AI, clinical data, and biomarker analytics — with CAHS’s world-class research expertise and testing capabilities. Together, the companies aim to validate and continually improve personalized supplement algorithms through rigorous clinical study and innovation.
“This is more than a business collaboration — it’s a convergence of science, spirit, and human potential,” said Dr. Bill Clark, Founder and CEO of NutriSelect. “Tim and the CAHS team are true pioneers. Together, we are building the infrastructure to empower people at scale with tools once only available to elite athletes and biohackers.”
The Center for Applied Health Sciences brings nearly two decades of expertise in human clinical trials, sports nutrition, regulatory compliance, and real-world product validation. Their commitment to translational science makes them the ideal partner as NutriSelect enters the next phase of development, focusing on biomarker-driven supplement recommendations.
“We’re thrilled to partner with NutriSelect,” said Dr. Tim Ziegenfuss, CEO of CAHS. “Dr. Clark’s vision aligns perfectly with our mission — to bring science-backed, personalized health solutions to the forefront of consumer health and wellness.”
As part of this collaboration, NutriSelect and CAHS will co-design clinical studies to ensure the platform’s algorithms remain not only innovative but scientifically robust. This LOI sets the stage for future equity discussions and expanded research pipelines across metabolic health, longevity, cognition, and more.
About NutriSelect.ai, Inc.
Founded by Dr. Bill Clark — chemist, inventor, and Top 100 Innovators & Entrepreneurs designee — NutriSelect.ai is a patent-pending, AI-powered platform delivering Precision Supplement Intelligence™. The system provides personalized, science-backed supplement recommendations by evaluating products through clinical evidence, biomarker alignment, and transparency standards. With integrated real-time health progress tracking and actionable wellness insights, NutriSelect empowers consumers to take control of their health, make confident choices, and optimize their long-term well-being.
NutriSelect is currently raising its pre-seed round and has been featured in NutraIngredients-USA, The Top 100 Innovators & Entrepreneurs for 2025, and the Founder Sense podcast. Email investment inquiries to Dr. Bill Clark.
About The Center for Applied Health Sciences
Based in Canfield, Ohio, CAHS is a premier CRO specializing in human clinical trials, performance nutrition, and regulatory strategy. Led by Dr. Tim Ziegenfuss, CAHS has been a trusted partner for major health brands around the globe, ensuring products are validated by rigorous science and real-world outcomes.
Dr. Bill Clark
NutriSelect.ai, Inc.
drbill@nutriselect.ai
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Frequently Asked Questions
What is NutriSelect.ai?
NutriSelect.ai is an AI-powered platform that provides personalized supplement recommendations based on clinical evidence, biomarker data, and transparency standards.
What is The Center for Applied Health Sciences (CAHS)?
CAHS is a contract research organization (CRO) specializing in human clinical trials, performance nutrition, and regulatory strategy.
What is the goal of the NutriSelect.ai and CAHS partnership?
The partnership aims to validate NutriSelect's AI supplement engine through rigorous clinical study and innovation, focusing on biomarker-driven supplement recommendations.
First published on Fri, Jun 13, 2025
Enjoyed what you read? Great news – there’s a lot more to explore!
Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!
Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.
Head to the TechDogs homepage to Know Your World of technology today!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending EIN Presswire
Colle AI Activates NFT Styling Layers For Real-Time Creator Experience
By EIN Presswire
Pistevo Decisions Ganbayar Gansukh Captures First Place In AWS Summit Washington, DC 2025 'LLM League' Challenge
By EIN Presswire
SXTC-DYADICA Releases Groundbreaking White Paper On AI 5.0: The Future Of Brand-Driven Artificial Intelligence
By EIN Presswire
Truck1.Eu Launches AI Assistants For Simplifying Commercial Vehicle Selection
By EIN Presswire
AGII Introduces Smart Process Mappers For Better Logic Monitoring
By EIN Presswire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion